SurfWax News Index  |  Track News  |  Save/Exchange Information |  About Us

    News and Articles on Psoriatic Arthritis



    Small businesses struggle to offer health care to employees  Nov 19, 2009
    Smith was surprised to discover that insurers wouldn t sell him an individual plan because of a diagnosis of psoriatic arthritis. So he now pays about 425 a month for a 5,000 deductible policy through Texas high risk insurance pool. (Coos Bay-North Bend The World, OR)

    Herbal Cures for Chronic Pain and I...  Oct 9, 2009
    In Eastern traditional medicines, however, it has long been used to treat inflammatory conditions like rheumatoid arthritis, osteoarthritis, fibromyalgia and psoriatic arthritis. Studies have also shown Ginger to be effective in treating. (Suite101.com)

    Cellceutix Compound Shows Significant Effect On Psoriasis  Oct 6, 2009
    Additionally, studies show that between 10 and 30 percent of people with psoriasis also develop psoriatic arthritis. Psoriasis greatly affects the quality of life of those with the disease; especially those with moderate to severe psoriasis. (Primezone Releases)

    Joint painmay be dueto psoriasis  Sep 30, 2009
    AUp to 30 percent of people with psoriasis develop psoriatic arthritis ... Psoriatic arthritis usually develops between the ages of 30 and 50 and often after psoriasis has been diagnosed on the body ... There are five variations of psoriatic arthritis. (Erie Times-News, PA)

    Abbott and Eisai Submit Application for Approval of Humira(R) for the Treatment of Crohn's Disease in Japan  Sep 30, 2009
    If approved, Crohn's disease will be the third indication for Humira, following rheumatoid arthritis (approved in April 2008) and psoriasis vulgaris and psoriatic arthritis (currently under review for approval). Adalimumab is a monoclonal antibody that neutralizes the activity of tumor necrosis factor alpha (TNF-alpha), a protein that plays a central role in inflammatory reactions in patients with autoimmune diseases. (JCN Network, Japan)

    Fines unlikely to end off-label drug marketing  Sep 5, 2009
    For example, the standard treatment for years for severe psoriatic arthritis was methotrexate, but the drug actually was approved to treat rheumatoid arthritis, said Dr. Eric Ruderman, a rheumatologist at the Northwestern University Feinberg School of Medicine. "If you had to stick to labeling, you couldn't treat people," said Ruderman, who has done some consulting work for Abbott Laboratories and received research grants from several drugmakers. (MSNBC -- Health)

    Gene variation is 'major genetic determinant of psoriasis'  Aug 28, 2009
    About 25 percent of subjects with the disease also develop a painful inflammation of the joints called psoriatic arthritis. University researchers, led by first author Bing-Jian Feng, Ph. (EurekAlert!)

    Clinic expands rheumatology practice  Aug 13, 2009
    Northwest Rheumatology specializes in the treatment of rheumatoid arthritis, scleroderma, Sjogren s Syndrome, psoriatic arthritis, lupus and other autoimmune diseases, as well as osteoporosis and osteoarthritis. The clinic has locations at 1140 Cypress Station Drive in Northwest Houston and at 9100 Forest Crossing Drive in The Woodlands. (Houston Business Journal, TX)

    Juvenile Arthritis: More than growing pains  Jul 21, 2009
    Psoriatic arthritis, which involves joint inflammation and stiffness and deformities of fingers and toes, runs on their dad's side of the family, Page said. Despite that medical background, Page didn't suspect juvenile arthritis when Billy developed a rash on his face, became fatigued and ran a low fever. (The Clarion-Ledger)

    Five Types of Psoriatic Arthritis  Jul 2, 2009
    A look into the five common forms of psoriatic arthritis, as well as how to treat them ... In many cases, individuals who suffer from psoriasis will also suffer from psoriatic arthritis ... It is estimated that as much as thirty percent of individuals with psoriasis also suffer from psoriatic arthritis. (Suite101.com)

    Risk of tuberculosis from arthritis medication examined  Jul 1, 2009
    Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and psoriasis. Most TB cases develop as a result of reactivation of a latent TB infection, and health authorities worldwide recommend screening for latent TB and treating patients before initiating anti-TNF treatment. (EurekAlert!)

    Increased Levels Of Certain Cytokines And Chemokines Predict Onset Of Rheumatoid Arthritis  Jul 1, 2009
    (June 11, 2009) Nulliparous women (those who have not given birth to children) are diagnosed with chronic arthritides (including ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis an average of 5. 2. (Science Daily)

    J&J unit wins $1.67 billion verdict vs Abbott Labs  Jun 30, 2009
    SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis. Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) adopted a positive opinion recommending the approval of SIMPONI(TM) (golimumab) as a once-monthly, subcutaneous therapy for the... (Fresno Bee -- Business)

    Relationship Between Bone Density And Erosion In Arthritis  Jun 16, 2009
    4, 2008) Rheumatologists, dermatologists and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects. (Sep. (Science Daily)

    National Psoriasis Survey reveals its devastating impact on quality of life  Jun 16, 2009
    The results of SKIN add a new dimension to the information available to us and we look forward to using the data to continue to educate Canadians," says Christine Jackson, Executive Director, Canadian Skin Patient Alliance and co-author of the SKIN publication. Gender Differences: Female Vs. Male Psoriasis Sufferers The SKIN study population was predominantly female (66 per cent). Female respondents ranked their disease as a more serious problem than did males and they were significantly more... (Canada Newswire)

    AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis  Jun 1, 2009
    Additional open label experience with AIMSPRO, over an extended period, has led Daval to consider Proof of Concept studies in Adhesive Arachnoiditis, treatment resistant Myasthenia Gravis and Psoriatic arthritis. AIMSPRO is listed on the Export Only section of the Australian Therapeutic Goods Registry and is imported into Europe by Biotec Distribution (Wales) Limited for clinical trial and "named patient use" purposes. (Canada Newswire)

    Chlamydia May Play Role In A Type Of Arthritis  May 7, 2009
    It includes ankylosing spondylitis (AS), psoriatic arthritis, inflammatory bowel-disease-related arthritis, reactive arthritis (ReA) and undifferentiated spondylarthritides (uSpA) ... 4, 2008) Rheumatologists, dermatologists and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects. (Science Daily)

    Centocor Ortho gets OK for Simponi  Apr 28, 2009
    received marketing approval from the Food and Drug Administration for Simponi, a treatment of moderate-to-severe rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The three diseases, combined, affect more than 3 million Americans. (Philadelphia Business Journal, PA)

    New Report by BioTrends Research Group to Highlight the Launch of SIMPONI(R) (golimumab)  Apr 28, 2009
    The first once-monthly subcutaneous anti-TNF-alpha therapy, SIMPONI is approved for the treatment of moderately to severely active rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis. The product will be available in two dosing delivery forms: the SIMPONI SmartJect autoinjector and a prefilled syringe. (PR Newswire)

    Faces in the crowd  Apr 17, 2009
    Affected by psoriatic arthritis since her early 20s, Merra had previously controlled the disease - which caused her joints to stiffen and swell - through exercise. But by age 46, it had worsened to the point where she "walked like a 90-year-old," she said. (Boston Globe)

    New Drug May Help Patients with Psoriatic Arthritis  Apr 11, 2009
    THURSDAY, April 9 (HealthDay News) -- The drug golimumab shows promise in treating psoriatic arthritis, according to a new study. Psoriatic arthritis affects about 11 percent of people with psoriasis ... The University of California, San Diego-led study included 405 patients who still had active psoriatic arthritis after taking anti-rheumatic drugs or nonsteroidal anti-inflammatory drugs. (MEDLINEplus)

    Psoriasis Drug Raptiva Pulled from U.S. Market  Apr 10, 2009
    Psoriasis is an autoimmune disease that usually shows up on the skin and can also manifest as psoriatic arthritis, according to the National Psoriasis Association. Genentech said Wednesday that it was working with Merck Serono, its licensee outside the United States and Japan, to inform other regulatory authorities of the drug's withdrawal from the U.S. market. (MEDLINEplus)

    New drug shows promising results for psoriatic arthritis  Apr 8, 2009
    Psoriatic arthritis affects about 11 percent of patients with psoriasis. Anti-tumor necrosis factor (anti-TNF ) agents, which block signaling molecules that induce inflammation, improve the symptoms of psoriatic arthritis ... A new phase III, multicenter, randomized, double-blind, placebo-controlled trial, the largest of its kind to be completed with a biologic agent to treat psoriatic arthritis and the first placebo-controlled study evaluating the effect of a TNF inhibitor on nail psoriasis,... (EurekAlert!)

    Unraveling psoriasisatthe genetic level  Apr 3, 2009
    org Established in 2005, Psoriasis Cure Now is a nonprofit dedicated to raising awareness and funds in order to find a cure for psoriasis and psoriatic arthritis ... We dont know if it will treat psoriatic arthritis as well there are some early suggestions that it will, but the studies havent been finished yet but it looks good for psoriasis. (MSNBC -- Health)

    Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis  Mar 20, 2009
    They have been also found in psoriatic arthritis (PsA), with controversies as regards clinical and radiological associations. The current study assessed anti-CCP in PsA and determined its clinical and radiological associations. (BioMed Central)

    KETV, Hearst-Argyle Recognized For Political Coverage  Mar 11, 2009
    offered viewers "thought-provoking and visually engaging stories about the presidential campaign. Reporter Greg Fox at WESH in Orlando, Fla., was honored for the second time in the category of individual achievement at a local station. Judges said Fox was recognized for his journalistic analysis and helping voters evaluate what candidates say in a "Truth Tests" series.Hearst-Argyle Television is a leading local media company with 26 television stations. The stations reach about 18 percent of... (7 KETV Omaha)

    Psoriatic Arthritis Treatment of Ustekinumab Effective, Study Suggests  Feb 23, 2009
    22, 2009) A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA) ... "This is a positive development for patients living with the joint pain and swelling that characterizes the disease, even as more research is needed to further test the efficacy of this... (Science Daily)

    FDA Warns Users on Psoriasis Drug  Feb 21, 2009
    Psoriasis is an autoimmune disease that usually shows up on the skin and can also manifest as psoriatic arthritis, according to the National Psoriasis Association. Tysabri (natalizumab), a drug used to treat multiple sclerosis, also carries risk for PML, according to the FDA. And other biologics approved for psoriasis carry risks. (MEDLINEplus)

    Antibody Useful for Psoriasis-Related Arthritis  Feb 20, 2009
    Dr. Alice Gottlieb, from Tufts Medical, Boston, and colleagues note that there is a need for drugs to treat psoriatic arthritis when standard treatments fail. Prior research has suggested that cell messenger proteins, called interleukin 12 and interleukin 23, play a role in the symptoms and joint damage seen in patients with psoriatic arthritis, the authors explain, and thus treatment with an agent that blocks these proteins may have a beneficial effect ... The effectiveness of "ustekinumab for... (MEDLINEplus)

    Psoriatic Arthritis Improves with Investigational Biologic  Feb 15, 2009
    " Ustekinumab has been approved in Europe for psoriasis. An application for U.S. marketing in psoriasis is pending. Unlike most other monoclonal antibody drugs, which require IV infusion, ustekinumab is generally delivered subcutaneously. The agent blocks interleukins 12 and 23 by binding to the P40 protein subunit that is a component of both. Previous studies have shown that this action disrupts the inflammatory cascade that is downstream of these interleukins, which plays an important role in... (MedPage Today)

    Recall Issued On Ground Beef Sold At H-E-B Store  Feb 15, 2009
    An exercise program is essential to managing psoriatic arthritis. But what kind of exercise is best, and how much exercise is appropriate. (Click2Houston, TX)

    TNF-Blocker Therapy for RA May Trigger Psoriasis  Feb 7, 2009
    "These findings present an interesting paradox," Hyrich pointed out, "as anti-TNF therapies are very effective in the treatment of severe psoriasis and psoriatic arthritis. The explanation behind these reported cases remains largely unknown.". "Further observation to understand their etiology is required," she concluded, "before any definite conclusions regarding the association between anti-TNF therapies and psoriasis can be made or guidelines for specific treatment of the condition issued.". (MEDLINEplus)

    Gene Insights May Improve Psoriasis Care  Feb 7, 2009
    In addition, 10 percent to 30 percent of patients develop psoriatic arthritis, a painful inflammation of the joints. Psoriasis can also increase the risk of coronary artery disease. (MEDLINEplus)

    Abnormal ECG Seen in Psoriatic Arthritis Patients  Feb 7, 2009
    NEW YORK (Reuters Health) - The results of a new study suggest that patients with psoriatic arthritis, a form of rheumatoid arthritis accompanied by psoriasis, may have "subtle" cardiac conduction disturbances ... "In surveying the literature, scant data were found regarding cardiac arrhythmias in psoriatic arthritis patients," researchers note in the Journal of Rheumatology ... Dr. Devy Zisman from Carmel Medical Center, Haifa, Israel, and colleagues compared the electrocardiogram (ECG) scans... (MEDLINEplus)



    Back to Health News

[ Terms Of Use | Privacy | About ]
©1998-2009 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2009